The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus

References

• Lockshin M D. Sex differences in autoimmune disease. Lupus 2006; 15: 753–756
   PubMed Web of Science ®Google Scholar
• Petri M, Robinson C. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 1997; 40: 797–803
   PubMed Web of Science ®Google Scholar
• Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy: the Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991; 34: 1538–1545
   PubMed Web of Science ®Google Scholar
• Costenbader K, Feskanich D, Stampfer M, Karlson E. Reproductive and menopausal factors and the risk of systemic lupus erythematosus in women. Arthritis Rheum 1997; 56: 1251–1262
   Google Scholar
• Verthelyi D, Ansar Ahmed S. Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice. J Autoimmun 1997; 10: 115–125
   PubMed Web of Science ®Google Scholar
• Roubinian J, Talal N, Siiteri P K, Sadakian J A. Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum 1979; 22: 1162–1169
   PubMed Web of Science ®Google Scholar
• Steinberg A D, Melez K A, Raveche E S, et al. Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum 1979; 22: 1170–1176
   PubMed Web of Science ®Google Scholar
• Peeva E, Venkatesh J, Diamond B. Tamoxifen blocks estrogen-induced B cell maturation but not survival. J Immunol 2005; 175: 1415–1423
   PubMed Web of Science ®Google Scholar
• Mok C, To C, Mak A, Ma K. Raloxifene for postmenopausal women with systemic lupus erythematosus. Arthritis Rheum 2005; 52: 3997–4002
   PubMed Web of Science ®Google Scholar
• Lahita R G, Bradlow H L, Kunkel H G, Fishman J. Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 1195–1198
   PubMed Web of Science ®Google Scholar
• Aronica S M, Dozier A, Fanit P, Nazareth M. Altered bone marrow cell sensitivity in the lupus-prone NZB/W mouse: regulation of CFU-Gm colony formation by estrogen, tamoxifen and thrombopoietin. Lupus 2000; 9: 271–277
   PubMed Web of Science ®Google Scholar
• Johansson M, Arlestig L, Moller B, Smedly T, Rantapaa-Dahlqvist S. Oestrogen receptor α gene polymorphisms in systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 1611–1617
   PubMed Web of Science ®Google Scholar
• Hal Scofield R, Brune G, Namjou B, et al. Kleinfelter's syndrome (47,XXY) in male systemic lupus erythematosus patients. Arthritis Rheum 2008; 58: 2511–2517
   PubMed Web of Science ®Google Scholar
• Paavonen T. Hormonal regulation of immune responses. Ann Med 1994; 26: 255–258
   PubMed Web of Science ®Google Scholar
• Rider V, Keltner S, Abdou N I. Increased estrogen-dependent expression of calineurin in female SLE T cells is regulated by multiple mechanisms. J Gend Specif Med 2003; 6: 14–21
   PubMedGoogle Scholar
• Bynoe M S, Grimaldi C M, Diamond B. Oestrogen up-regulates Bcl-2 and blocks tolerance induction of naïve B cells. Proc Natl Acad Sci USA 2000; 97: 2703–2708
   PubMed Web of Science ®Google Scholar
• Grimaldi C M. Sex and systemic lupus erythematosus: the role of the sex hormones oestrogen and prolactin on the regulation of autoreactive B cell. Curr Opin Rheumatol 2006; 18: 456–461
   PubMed Web of Science ®Google Scholar
• Hu S K, Mitcho Y L, Rath N C. Effect of estradiol on interleukin 1 synthesis by macrophages. Int J Immuno-Pharmacol 1999; 10: 247–252
   Google Scholar
• Evans M J, MacLaughlin S, Marvin R D, Abdou N I. Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells in women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures. Clin Immunol Immunopathol 1997; 82: 258–262
   PubMedGoogle Scholar
• Innui A, Ogasawara H, Naito T, et al. Estrogen receptor expression in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clin Rheumatol 2007; 26: 1675–1678
   PubMed Web of Science ®Google Scholar
• Kassi E, Vlachoyiannopoulos P G, Kominakis A, Kiaris H, Moutsopolos H M, Moutatsou P. Estrogen receptor alpha gene polymorphism and systemic lupus erythematosus: a possible risk. Lupus 2005; 14: 391–398
   PubMed Web of Science ®Google Scholar
• Svenson J L, EuDaly J, Ruiz P, Korach K S, Gilkeson G S. Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin Immunol 2008; 128: 259–268
   PubMed Web of Science ®Google Scholar
• Li J, McMurray R W. Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/NZW F1 mouse model. Clin Immunol 2007; 123: 219–226
   PubMed Web of Science ®Google Scholar
• Peeva E, Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett 2005; 101: 123–143
   PubMed Web of Science ®Google Scholar
• Elbourne K B, Keisler D, McMurray R W. Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus. Lupus 1998; 7: 420–427
   PubMed Web of Science ®Google Scholar
• Walker S E. Modulation of hormones in the treatment of lupus. Am J Manag Care 2001; 7(Suppl 16)S486–S489
   Google Scholar
• Petri M. Sex hormones and systemic lupus erythematosus. Lupus 2008; 17: 412–415
   PubMed Web of Science ®Google Scholar
• Van Griensven M, Bergijk E C, Baelde J J, De heer E, Bruijn J A. Differential effects of sex hormones on autoantibody production and proteinuria in chronic graft-versus host disease-induced experimental lupus nephritis. Clin Exp Immunol 1997; 107: 254–260
   PubMed Web of Science ®Google Scholar
• Liu C, Zhou H, Qu R, Liu Z. Effects of sex hormones on apoptosis in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Chin Med J 2001; 114: 291–293
   PubMed Web of Science ®Google Scholar
• Suzuki N, Suzuki T, Sakane T. Hormones and lupus: defective dehydroepiandrosterone activity induces impaired interleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosus. Ann Intern Med 1996; 147: 248–252
   Google Scholar
• Lucas J A, Ahmed S A, Casey M L, Macdonald P C. Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice fed dehydroisoandrosterone. J Clin Invest 1983; 75: 2091–2093
   Web of Science ®Google Scholar
• Yang B C, Liu C W, Chen Y C, Yu C K. Exogenous dehydroepiandrosterone modified the expression of T helper-related cytokines in NZB/NZW F1 mice. Immunol Invest 1998; 27: 291–302
   PubMed Web of Science ®Google Scholar
• Costenbader K, Manson J. Do female hormones affect the onset or severity of rheumatoid arthritis. Arthritis Rheum 2008; 59: 299–301
   PubMed Web of Science ®Google Scholar
• Nielsen R, Christiansen C, Stolina M, Karsdal M. Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats. Clin Exp Immunol 2008; 152: 21–27
   PubMed Web of Science ®Google Scholar
• Capellino S, Montagna P, Villaggio B, Soldano S, Straub R H, Cutolo M. Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia. Clin Exp Rheumatol 2008; 26: 903–909
   PubMed Web of Science ®Google Scholar
• Cutolo M, Sulli A, Cpellino S, et al. Anti-TNF and sex hormones. Ann NY Acad Sci 2006; 1069: 391–400
   PubMed Web of Science ®Google Scholar
• Bonnelye E, Laurin N, Jurdic P, Hart D, Aubin J. Estrogen receptor-related receptor alpha is dysregulated in inflammatory arthritis. Rheumatology 2008; 47: 1785–1791
   PubMed Web of Science ®Google Scholar
• Barrett C, Neylon N, Smith M L. Oestrogen-induced systemic lupus erythematosus. Br J Rheumatol 1986; 23: 300–301
   Google Scholar
• Meier C R, Sturkenboom M C, Cohen A S, Jick H. Postmenopausal estrogen replacement and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol 1999; 25: 1515–1519
   Web of Science ®Google Scholar
• Arden N K, Lloyd M E, Spector T D, Hughes G RV. Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE). Lupus 1994; 3: 11–13
   PubMed Web of Science ®Google Scholar
• Kreidstein S, Urowitz M B, Gladman D D, Gough J. Hormone replacement therapy in systemic lupus erythematosus. J Rheumatol 1997; 24: 2149–2152
   PubMed Web of Science ®Google Scholar
• Sanchez-Guerrero J, Gonzalez-Perez M, Durand-Carbajal M, et al. Menopause hormonal therapy in women with systemic lupus erythematosus. Arthritis Rheum 2007; 56: 3070–3079
   PubMed Web of Science ®Google Scholar
• Mok C C, Lau C S, Ho C T, Lee K W, Mok M Y, Wong R W. Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus. Scand J Rheumatol 1998; 27: 342–346
   PubMed Web of Science ®Google Scholar
• Buyon J P, Petri M A, Kim M Y, et al. The effect of combined oestrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomised trial. Ann Intern Med 2005; 142: 953–962
   PubMed Web of Science ®Google Scholar
• D'Elia H F, Larsen A, Mattsson L A, et al. Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. J Rheumatol 2003; 30: 1456–1463
   PubMed Web of Science ®Google Scholar
• MacDonald A G, Murphy E A, Capell H A, Bankowska U Z, Ralston S H. Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study. Ann Rheum Dis 1994; 53: 54–57
   PubMed Web of Science ®Google Scholar
• van der Brink H R, van Everdingen A A, van Wijik M J, et al. Adjuvant estrogen therapy does not influence disease activity in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis 1993; 52: 862–865
   PubMed Web of Science ®Google Scholar
• Hall G M, Daniels M, Huskinsson E C, Spector T D. A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis 1994; 53: 112–116
   PubMed Web of Science ®Google Scholar
• Walitt B, Pettinger M, Weinstein A, et al. Effects of postmenopausal hormone therapy on rheumatoid arthritis: the Women's Health Initiative randomised controlled trials. Arthritis Rheum 2008; 59: 302–310
   PubMed Web of Science ®Google Scholar
• Cutolo M. Sex hormone adjuvanting therapy in rheumatoid arthritis. Lupus 2002; 11: 670–674
   PubMed Web of Science ®Google Scholar
• Margolis H M, Caplan P S. The effect of some steroids in rheumatoid arthritis. Ann Intern Med 1951; 34: 61–71
   PubMed Web of Science ®Google Scholar
• Bird H A, Burkinshaw L, Pearson D, et al. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women. Ann Rheum Dis 1987; 46: 237–243
   PubMed Web of Science ®Google Scholar
• Booji A, Biewenga-Booji C M, Huber-Brunning O, et al. Androgens as adjuvant therapy in postmenopausal patients with rheumatoid arthritis. Ann Rheum Dis 1996; 55: 81–15
   Google Scholar
• Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991; 34: 1–5
   PubMed Web of Science ®Google Scholar
• Hall G M, Larbre J P, Spector T D, Perry L A, Da Silva J A. A randomised trial of testosterone therapy in male patients with rheumatoid arthritis. Br J Rheumatol 1996; 35: 568–573
   PubMedGoogle Scholar
• van Vollenhoven R F, Morabito L M, Engleman E G, McGuire J L. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. J Rheumatol 1998; 25: 285–289
   PubMed Web of Science ®Google Scholar
• Petri M, Lahita R, McGuire J, et al. Results of the GL710 (DHEA) multicenter steroid-sparing SL study. Arthritis Rheum 1997; 40: S327
   Google Scholar
• Chang D M, Lan J I, Lin L I, Luo S F. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2003; 5: 348–349
   Google Scholar
• Gompel A, Piette J C. Systemic lupus erythematosus and hormone replacement therapy. Menopause Int 2007; 13: 65–70
   PubMedGoogle Scholar